L. Noens
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
Papers in
- Hematology 11
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 2
- Oncology 7
- Neutropenia and Cancer Infections 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Gerhard HeilArnold GanserMiguel Á. SanzKlaus LechnerJames MatchamJeff SzerAlan BargeCaroline O’Brien
- Journals
- Blood (3 papers)Leukemia (2 papers)Genes Chromosomes and Cancer (1 paper)American Journal of Obstetrics and Gynecology (1 paper)Immunogenetics (1 paper)
- Partner nations
- BelgiumGermanyUnited Kingdom
In The Last Decade
L. Noens
16 papers receiving 560 citations
Peers
Comparison fields: 5 of 50
- Hematology 351
- Ophthalmology 75
- Oncology 199
- Genetics 66
- Emergency Medicine 55
Countries citing papers authored by L. Noens
This map shows the geographic impact of L. Noens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Noens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Noens more than expected).
Fields of papers citing papers by L. Noens
This network shows the impact of papers produced by L. Noens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Noens. The network helps show where L. Noens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Noens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HOVON 104; FINAL RESULTS FROM A MULTICENTER, PROSPECTIVE PHASE II STUDY OF BORTEZOMIB BASED INDUCTION TREATMENT FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH DE NOVO AL AMYLOIDOSIS | 2017 | 1 |
| 2 | 2014 | 7 | |
| 3 | 2012 | 12 | |
| 4 | 2008 | 19 | |
| 5 | 2006 | 15 | |
| 6 | 2006 | 6 | |
| 7 | 2004 | 42 | |
| 8 | 2002 | 40 | |
| 9 | 2001 | 80 | |
| 10 | FISH identifies inv(16)(p13q22) masked by translocations in three cases of AML | 1997 | 1 |
| 11 | 1997 | 11 | |
| 12 | 1997 | 231 | |
| 13 | Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia | 1995 | 12 |
| 14 | 1992 | 19 | |
| 15 | 1988 | 70 | |
| 16 | 1984 | 6 |
About L. Noens
L. Noens is a scholar working on Hematology, Oncology, Ophthalmology, Immunology and Allergy and Management of Technology and Innovation, having authored 16 papers that have together received 572 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Ocular Infections and Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers), Ocular Diseases and Behçet’s Syndrome (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Hematology (351 citations), Ophthalmology (75 citations), Oncology (199 citations), Genetics (66 citations) and Emergency Medicine (55 citations). L. Noens has collaborated with scholars based in Belgium, Germany and United Kingdom. Frequent co-authors include Gerhard Heil, Arnold Ganser, Miguel Á. Sanz, Klaus Lechner, James Matcham, Jeff Szer, Alan Barge, Caroline O’Brien, Giuseppe Francesco Sferrazza Papa and Dieter Hoelzer. Their work appears in journals such as Blood, Leukemia, Genes Chromosomes and Cancer, American Journal of Obstetrics and Gynecology and Immunogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.